Table 2.
Electrocardiographic in-hospital findings among patients with double or triple therapy for COVID-19.
| All patients (n = 168) |
Double therapy (n = 54) |
Triple therapy (n = 114) |
p-Value | |
|---|---|---|---|---|
| Sinus rhythm (%) | 153.0 (91.1) | 46.0 (85.2) | 107.0 (93.9) | 0.083 |
| Bundle branch block (%) | 18.0 (10.7) | 5.0 (9.3) | 13.0 (11.4) | 0.675 |
| Baseline QTc (ms) | 410.3 ± 33.9 | 408.0 ± 34.0 | 411.3 ± 34.0 | 0.558 |
| Prolonged baseline QTc (%) | 18.0 (10.7) | 5.0 (9.3) | 13.0 (11.4) | 0.675 |
| QTc peak (ms) | 440.6 ± 36.3 | 439.2 ± 38.2 | 441.2 ± 35.5 | 0.748 |
| Δ QTc (ms) | 30.3 ± 34.6 | 31.2 ± 30.6 | 29.8 ± 36.5 | 0.813 |
| Prolonged QTc peak (%) | 53.0 (31.6) | 20.0 (37.0) | 33.0 (29.0) | 0.292 |
| QTc prolongation ≥ 60 ms (%) | 27.0 (16.1) | 6.0 (11.1) | 21.0. (18.4) | 0.228 |
| QTc peak ≥ 500 ms (%) | 9.0 (5.4) | 2.0 (3.7) | 7.0 (6.1) | 0.720 |
| High risk QTc peak (%) | 33.0 (19.6) | 7.0 (13.0) | 26.0 (22.8) | 0.134 |
QTc: corrected QT interval, BPM: beats per minute, MS: milliseconds.